Acer Medical Inc. (TPEX:6857)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
98.50
+2.50 (2.60%)
May 8, 2026, 9:41 AM CST
Market Cap1.50B -27.0%
Revenue (ttm)60.05M +19.7%
Net Income-29.69M
EPS-1.95
Shares Out15.23M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume20
Average Volume2,077
Open98.50
Previous Close96.00
Day's Range98.50 - 98.50
52-Week Range96.00 - 158.50
Beta0.75
RSI49.67
Earnings DateApr 24, 2026

About Acer Medical

Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. It offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan. [Read more]

Sector Healthcare
Founded 2018
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6857
Full Company Profile

Financial Performance

In 2025, Acer Medical's revenue was 60.05 million, an increase of 19.73% compared to the previous year's 50.16 million. Losses were -29.69 million, 8.49% more than in 2024.

Financial Statements